totient.bio Revenue and Competitors
Estimated Revenue & Valuation
- totient.bio's estimated annual revenue is currently $775k per year.
- totient.bio's estimated revenue per employee is $155,000
Employee Data
- totient.bio has 5 Employees.
- totient.bio grew their employee count by 0% last year.
totient.bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CBO | Reveal Email/Phone |
2 | VP, Platform & Collaborations | Reveal Email/Phone |
3 | VP Machine Learning & Bioinformatics | Reveal Email/Phone |
4 | Senior Director Antibody Engineering & Development | Reveal Email/Phone |
totient.bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is totient.bio?
Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Totient reconstructs antibodies from tissues affected by autoimmunity, infections, and cancer collected from patients experiencing exceptional immune responses. Beginning with a population of over 50,000 samples, we have reconstructed antibodies against known and novel extracellular oncology targets: GAGE1, GAGE2A, ANXA1, C4BPB, IL14A, BIRC7, HCLS1, GPR83, and others undisclosed.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.6M | 5 | -17% | N/A |
#2 | $0.4M | 5 | 25% | $52.5M |
#3 | $0.1M | 5 | 0% | $4.5M |
#4 | $0.8M | 5 | -17% | N/A |
#5 | $0.4M | 5 | -17% | N/A |